ROSLIN CELL SCIENCES LIMITED

Active Midlothian

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
R

ROSLIN CELL SCIENCES LIMITED

Research and experimental development on biotechnology

Founded 4 Aug 2015 Active Midlothian, Scotland 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

QUILLCO 232 LIMITED 4 Aug 2015 — 9 Sept 2015
Accounts Submitted 11 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 29 Aug 2025 Next due 7 Aug 2026 2 months remaining
Net assets £183K £75K 2023 year on year
Total assets £253K £3K 2023 year on year
Total Liabilities £69K £72K 2023 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Roslin Innovation Centre Charnock Bradley Building Easter Bush Campus Midlothian EH25 9RG Scotland

Full company profile for ROSLIN CELL SCIENCES LIMITED (SC512311), an active company based in Midlothian, Scotland. Incorporated 4 Aug 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2015–2023)

Cash in Bank

N/A

Decreased by £7.58k (-100%)

Net Assets

£183.28k

Increased by £75.34k (+70%)

Total Liabilities

£69.50k

Decreased by £71.87k (-51%)

Turnover

N/A

Employees

N/A

Debt Ratio

27%

Decreased by 30 (-53%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Liam Mark TaylorDirectorAustralianWales4916 Mar 2021Active

Shareholders

Shareholders (1)

Censo Biotechnologies Ltd
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 29 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

ROSLIN CELL SCIENCES LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 Jan 2026ResolutionResolutions
6 Jan 2026IncorporationMemorandum Articles
31 Dec 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
11 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
29 Aug 2025Confirmation StatementConfirmation statement made on 24 Jul 2025 with no updates
6 Jan 2026 Resolution

Resolutions

6 Jan 2026 Incorporation

Memorandum Articles

31 Dec 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

11 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

29 Aug 2025 Confirmation Statement

Confirmation statement made on 24 Jul 2025 with no updates

Recent Activity

Latest Activity

Resolutions

5 months ago on 6 Jan 2026

Memorandum Articles

5 months ago on 6 Jan 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

5 months ago on 31 Dec 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 11 Sept 2025

Confirmation statement made on 24 Jul 2025 with no updates

9 months ago on 29 Aug 2025